AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read MoreThe ISAD–WHO course on atopic dermatitis in Black skin is now available, in addition to the WHO Academy platform, on the newly launched ILDS Skin Health Training Hub. Atopic Dermatitis with focus on Sub-Saharan Africa: Training for national and district-level health workers To access the course, you can either use this link https://whoacademy.org/ or type the […]
Read MoreSave the date! March 30, 08:00 – 09:30 am Denver Time (MDT, UTC-6), via ZoomZürich time (CEST, UTC+2): 16:00 – 17:30Duration: 90 minutes Introduction The ISAD-OPENED Task Force will hold its first biannual meeting of 2026 during the AAD Congress in Denver, Colorado. Following a survey conducted among our members, this meeting will be held […]
Read MoreAPPLY BEFORE APRIL FIRST! Are you an early-career dermatologist or researcher in epidemiology or public health? The ISAD-GADA Fellowship offers the chance to work with the Global Atopic Dermatitis Atlas (GADA) team, develop key research skills, and lead a small research project! The GADA team will provide state-of-the-art training in epidemiological research methodology, guiding fellows […]
Read MoreWe are pleased to highlight the latest research from Dr. Erere Otrofanowei, a recipient of the ISAD Research Fellowship. The new publication, titled “Accessibility And Affordability Of Emollients In The Management Of Atopic Dermatitis (AD) In Africa”, has been featured in the Journal of Investigative Dermatology (JID). Building on her fellowship work conducted at the […]
Read MoreThe Ethics of Prescribing and Access in Atopic Dermatitis: Can We Separate Them? Therapeutic innovation in atopic dermatitis (AD) has advanced rapidly. Biologics and targeted therapies have transformed the outlook for patients with severe disease. Yet a central ethical tension is emerging: what is the value of prescribing the best treatment if patients cannot access […]
Read MoreProf Kin Fon LEONG from Malaysia kindly shares his book with the ISAD community — many thanks! Two educative booklets from Malaysia Fore word Dr Yong Kwang TAY, FRCPSingapore
Read MoreA New Chapter in International Partnership We are pleased to announce the signature of a Memorandum of Understanding (MoU) between the International Society of Atopic Dermatitis (ISAD) and the European Academy of Allergy and Clinical Immunology (EAACI), formalizing a strengthened collaboration between our two societies. This partnership reflects our shared commitment to advancing excellence in patient care, education, and research […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read MoreYou are invited! DEADLINE FRIDAY 6 FEBRUARY 2026 As a board- certified dermatologist practicing in an African country, you are invited to participate in a modified e-Delphi consensus process to support the development of the African Clinical Practice Guidelines for the Diagnosis and Management of Atopic Dermatitis (Eczema), led by the African Society of Dermatology […]
Read More